Tripod provides preclinical research services for global pharma companies, R&D enterprises and institutes and medical device developers.
Tripod is a Contract Research Organization in the biopharmaceutical space that provides preclinical research services for global pharma companies, R&D enterprises and institutes, and medical device developers. Tripod (TPR) is dedicated to nonclinical research (drug safety evaluation) for the candidates of new chemical entity (NCE), food additives, biologics,pesticides,veterinary drugs, and new cosmetics.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 5, 2021 | Series Unknown | ¥1B | 2 | Ruihua Venture Capital Lilly Asia Ventures | — | Detail |
Aug 1, 2018 | Secondary Market | — | 1 | Wuhan Lihe Chemical New Material | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Ruihua Venture Capital | Yes | Series Unknown |
Lilly Asia Ventures | Yes | Series Unknown |
Wuhan Lihe Chemical New Material | Yes | Secondary Market |